Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2690.72 | 1445 / 1445 | 100% | 57.43 | 183 / 183 |
liver | 100% | 2593.49 | 226 / 226 | 100% | 147.46 | 406 / 406 |
ovary | 100% | 3112.81 | 180 / 180 | 100% | 104.45 | 430 / 430 |
pancreas | 100% | 2882.02 | 328 / 328 | 100% | 113.77 | 178 / 178 |
brain | 100% | 3447.15 | 2641 / 2642 | 100% | 115.40 | 705 / 705 |
thymus | 100% | 3560.77 | 653 / 653 | 100% | 141.08 | 604 / 605 |
kidney | 100% | 2897.12 | 89 / 89 | 100% | 109.08 | 898 / 901 |
stomach | 100% | 2941.08 | 359 / 359 | 100% | 101.81 | 285 / 286 |
skin | 100% | 2958.55 | 1809 / 1809 | 100% | 120.92 | 470 / 472 |
uterus | 100% | 3357.41 | 170 / 170 | 99% | 120.90 | 456 / 459 |
intestine | 100% | 2700.30 | 966 / 966 | 99% | 121.63 | 523 / 527 |
prostate | 100% | 3249.11 | 245 / 245 | 99% | 152.77 | 498 / 502 |
breast | 100% | 3018.42 | 459 / 459 | 99% | 127.45 | 1109 / 1118 |
lung | 100% | 3515.58 | 578 / 578 | 99% | 102.14 | 1144 / 1155 |
bladder | 100% | 2833.10 | 21 / 21 | 99% | 127.48 | 497 / 504 |
adrenal gland | 100% | 5189.61 | 258 / 258 | 98% | 130.92 | 226 / 230 |
adipose | 100% | 2691.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 178.24 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 97.76 | 29 / 29 |
spleen | 100% | 2383.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 91.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 69.32 | 1 / 1 |
blood vessel | 100% | 2779.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2148.45 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1589.55 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1573.16 | 893 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901800 | Biological process | positive regulation of proteasomal protein catabolic process |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_1905552 | Biological process | positive regulation of protein localization to endoplasmic reticulum |
GO_0033146 | Biological process | regulation of intracellular estrogen receptor signaling pathway |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_1903895 | Biological process | negative regulation of IRE1-mediated unfolded protein response |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0140501 | Biological process | positive regulation of reticulophagy |
GO_1990592 | Biological process | protein K69-linked ufmylation |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_1905050 | Biological process | positive regulation of metallopeptidase activity |
GO_0070972 | Biological process | protein localization to endoplasmic reticulum |
GO_0032790 | Biological process | ribosome disassembly |
GO_0071569 | Biological process | protein ufmylation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1903898 | Biological process | negative regulation of PERK-mediated unfolded protein response |
GO_1903721 | Biological process | positive regulation of I-kappaB phosphorylation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061709 | Biological process | reticulophagy |
GO_1905636 | Biological process | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
GO_1900100 | Biological process | positive regulation of plasma cell differentiation |
GO_0051216 | Biological process | cartilage development |
GO_0031647 | Biological process | regulation of protein stability |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0141185 | Molecular function | UFM1-modified protein reader activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
Gene name | DDRGK1 |
Protein name | DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1) DDRGK domain-containing protein 1 |
Synonyms | C20orf116 UFBP1 |
Description | FUNCTION: Substrate adapter for ufmylation, the covalent attachment of the ubiquitin-like modifier UFM1 to substrate proteins, which plays a key role in reticulophagy (also called ER-phagy) . In response to endoplasmic reticulum stress, promotes recruitment of the E3 UFM1-protein ligase UFL1 to the endoplasmic reticulum membrane: in turn, UFL1 mediates ufmylation of proteins such as RPN1 and RPL26/uL24, promoting reticulophagy of endoplasmic reticulum sheets . Ufmylation-dependent reticulophagy inhibits the unfolded protein response (UPR) by regulating ERN1/IRE1-alpha stability . Ufmylation in response to endoplasmic reticulum stress is essential for processes such as hematopoiesis or inflammatory response (By similarity). Required for TRIP4 ufmylation, thereby regulating nuclear receptors-mediated. transcription . May play a role in NF-kappa-B-mediated transcription through regulation of the phosphorylation and the degradation of NFKBIA, the inhibitor of NF-kappa-B . Plays a role in cartilage development through SOX9, inhibiting the ubiquitin-mediated proteasomal degradation of this transcriptional regulator . . |
Accessions | Q96HY6 ENST00000354488.8 [Q96HY6-1] ENST00000380201.2 A0A0A0MRX2 |